This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ma, Q. Articles by Bai, W. Search for Related Content PubMed PubMed Citation Articles by Ma, Q. Articles by Bai, W.

FoxO1 Mediates PTEN Suppression of Androgen Receptor N- and C-Terminal Interactions and Coactivator Recruitment

Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.) and Interdisciplinary Oncology (S.V.N., X.Z., W.B.), University of South Florida College of Medicine and Programs of Molecular Oncology (X.Z., W.B.) and Experimental Therapeutics (S.V.N.), H. Lee Moffitt Cancer Center, Tampa, Florida 33612-4799; and Department of Urology (G.J.), Josephine Nefkens Institute, Be362a, Erasmus MC, the Netherlands

Address all correspondence and requests for reprints to: Wenlong Bai, Ph.D., Departments of Pathology and Cell Biology, University of South Florida, College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 11, Tampa, Florida 33612-4799. E-mail: wbai{at}health.usf.edu.

FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150–655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.

NURSA Molecule Pages Link:

Nuclear Receptors:   AR

Coregulators:   PTEN  |  SRC-1  |  GRIP1  |  AIB1

Ligands:   Dihydrotestosterone  |  R1881

This article has been cited by other articles:

				L. Gan, S. Chen, Y. Wang, A. Watahiki, L. Bohrer, Z. Sun, Y. Wang, and H. Huang Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer Cancer Res., November 1, 2009; 69(21): 8386 - 8394. [Abstract] [Full Text] [PDF]